Mowery & Schoenfeld Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Mowery & Schoenfeld Wealth Management's BMY Position: Q1 2026 in Review
Mowery & Schoenfeld Wealth Management held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 275 shares worth $16.7K. The position accounts for 0.03% of the portfolio, ranked #184.
Mowery & Schoenfeld Wealth Management first reported a position in BMY in Q4 2024 and has held it in 6 quarters since. The position peaked at $17.6K in Q4 2024. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Mowery & Schoenfeld Wealth Management held 275 shares of Bristol-Myers Squibb worth $16.7K as of Q1 2026.
- Mowery & Schoenfeld Wealth Management left its Bristol-Myers Squibb share count unchanged in Q1 2026.
- Bristol-Myers Squibb made up 0.03% of Mowery & Schoenfeld Wealth Management's portfolio in Q1 2026, its #184 holding.
- Mowery & Schoenfeld Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 6 quarters since.
- Mowery & Schoenfeld Wealth Management's Bristol-Myers Squibb position peaked at $17.6K in Q4 2024.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Mowery & Schoenfeld Wealth Management's 13F filing for Q1 2026, filed 1 May 2026.